- Filed
- Feb 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 13, 2026 | 204.38M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 205.3M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 204.65M sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 203.94M sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $0 |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $0 |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $4.81M |
| Dividends Paid | FY 2025 · Dec 31, 2025 | $108.24M |
| Dividends Paid | FY 2025 · Dec 31, 2024 | $102.94M |
| Dividends Paid | FY 2025 · Dec 31, 2023 | $161.32M |
| Capex | FY 2025 · Dec 31, 2025 | $770.39M |
| Capex | FY 2025 · Dec 31, 2024 | $522.82M |
| Capex restated | FY 2025 · Dec 31, 2023 | $484.14M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $473.37M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $502.32M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | $332.63M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $2.53B |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $2.13B |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $28.21M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $66.9M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $2.77B |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $2.69B |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $2.91B |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $3.59B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $685.22M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $678.6M |
| Current Assets | FY 2025 · Dec 31, 2025 | $572.44M |
| Current Assets | FY 2025 · Dec 31, 2024 | $666.26M |
| Total Assets | FY 2025 · Dec 31, 2025 | $7.62B |
| Total Assets | FY 2025 · Dec 31, 2024 | $7.04B |
| Total Assets | FY 2025 · Dec 31, 2023 | $7.83B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $0.93 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $1.37 |
| Eps Diluted | FY 2025 · Dec 31, 2023 | $2.03 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $0.93 |
| Eps Basic | FY 2025 · Dec 31, 2024 | $1.38 |
| Eps Basic | FY 2025 · Dec 31, 2023 | $2.04 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $433.02M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $414.49M |
| Sga Expense restated | FY 2025 · Dec 31, 2023 | $407.08M |
| Net Income | FY 2025 · Dec 31, 2025 | $190.4M |
| Net Income | FY 2025 · Dec 31, 2024 | $281.11M |
| Net Income | FY 2025 · Dec 31, 2023 | $414.71M |
| Operating Income | FY 2025 · Dec 31, 2025 | $290.38M |
| Operating Income | FY 2025 · Dec 31, 2024 | $265.64M |
| Operating Income restated | FY 2025 · Dec 31, 2023 | $224.94M |
| Revenue | FY 2025 · Dec 31, 2025 | $1.86B |
| Revenue | FY 2025 · Dec 31, 2024 | $1.75B |
| Revenue restated | FY 2025 · Dec 31, 2023 | $1.81B |